Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition.

Chao YL, Shepard CR, Wells A.

Mol Cancer. 2010 Jul 7;9:179. doi: 10.1186/1476-4598-9-179.

2.

Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition.

Arima Y, Inoue Y, Shibata T, Hayashi H, Nagano O, Saya H, Taya Y.

Cancer Res. 2008 Jul 1;68(13):5104-12. doi: 10.1158/0008-5472.CAN-07-5680.

3.

Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition.

Mejlvang J, Kriajevska M, Berditchevski F, Bronstein I, Lukanidin EM, Pringle JH, Mellon JK, Tulchinsky EM.

Exp Cell Res. 2007 Jan 15;313(2):380-93. Epub 2006 Oct 26.

PMID:
17141758
4.

The role of epithelial-mesenchymal transition in cancer pathology.

Guarino M, Rubino B, Ballabio G.

Pathology. 2007 Jun;39(3):305-18. Review.

PMID:
17558857
5.

Stromal fibroblasts from the interface zone of human breast carcinomas induce an epithelial-mesenchymal transition-like state in breast cancer cells in vitro.

Gao MQ, Kim BG, Kang S, Choi YP, Park H, Kang KS, Cho NH.

J Cell Sci. 2010 Oct 15;123(Pt 20):3507-14. doi: 10.1242/jcs.072900. Epub 2010 Sep 14.

6.
7.
8.

Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype.

Sarrió D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J.

Cancer Res. 2008 Feb 15;68(4):989-97. doi: 10.1158/0008-5472.CAN-07-2017.

9.
10.

Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.

Lim SO, Gu JM, Kim MS, Kim HS, Park YN, Park CK, Cho JW, Park YM, Jung G.

Gastroenterology. 2008 Dec;135(6):2128-40, 2140.e1-8. doi: 10.1053/j.gastro.2008.07.027. Epub 2008 Jul 31.

PMID:
18801366
11.
12.

Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.

Li Z, Ren Y, Lin SX, Liang YJ, Liang HZ.

Chin Med J (Engl). 2004 Aug;117(8):1232-9.

PMID:
15361301
13.

A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition.

Pampalakis G, Prosnikli E, Agalioti T, Vlahou A, Zoumpourlis V, Sotiropoulou G.

Cancer Res. 2009 May 1;69(9):3779-87. doi: 10.1158/0008-5472.CAN-08-1976. Epub 2009 Apr 21.

14.

Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells.

Veveris-Lowe TL, Lawrence MG, Collard RL, Bui L, Herington AC, Nicol DL, Clements JA.

Endocr Relat Cancer. 2005 Sep;12(3):631-43.

15.

Altered expression of adhesion molecules and epithelial-mesenchymal transition in silica-induced rat lung carcinogenesis.

Blanco D, Vicent S, Elizegi E, Pino I, Fraga MF, Esteller M, Saffiotti U, Lecanda F, Montuenga LM.

Lab Invest. 2004 Aug;84(8):999-1012.

16.

KCl cotransporter-3 down-regulates E-cadherin/beta-catenin complex to promote epithelial-mesenchymal transition.

Hsu YM, Chen YF, Chou CY, Tang MJ, Chen JH, Wilkins RJ, Ellory JC, Shen MR.

Cancer Res. 2007 Nov 15;67(22):11064-73.

17.

Oncologic trogocytosis with Hospicells induces the expression of N-cadherin by breast cancer cells.

Lis R, Capdet J, Mirshahi P, Lacroix-Triki M, Dagonnet F, Klein C, Mirshahi M, Fournié JJ, Rafii A, Poupot M.

Int J Oncol. 2010 Dec;37(6):1453-61.

PMID:
21042713
18.
19.

E-cadherin and DAP kinase in pancreatic adenocarcinoma and corresponding lymph node metastases.

Dansranjavin T, Möbius C, Tannapfel A, Bartels M, Wittekind C, Hauss J, Witzigmann H.

Oncol Rep. 2006 May;15(5):1125-31.

PMID:
16596173
20.

Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin.

Kudo Y, Kitajima S, Ogawa I, Hiraoka M, Sargolzaei S, Keikhaee MR, Sato S, Miyauchi M, Takata T.

Clin Cancer Res. 2004 Aug 15;10(16):5455-63.

Supplemental Content

Support Center